Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mannitol for acute stroke.

D Bereczki1, M Liu, G F do Prado

  • 1Department of Neurology, University of Debrecen, Health Science and Medical Center, Nagyerdei krt. 98., Debrecen, Hungary, H-4012. bereczki@jaguar.dote.hu

The Cochrane Database of Systematic Reviews
|May 2, 2001
PubMed
Summary

Limited evidence exists regarding mannitol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic.

European journal of neurology·2020
Same author

The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection.

European journal of neurology·2020
Same author

Demand for neurological services in Central Eastern Europe: a 10-year national survey in Hungary.

European journal of neurology·2018
Same author

Health-Related Quality of Life in Migraine Without Aura Based on Attack Frequency: A time Trade-Off Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Valproate treatment normalizes EEG functional connectivity in successfully treated idiopathic generalized epilepsy patients.

Epilepsy research·2014
Same author

Comparing ischaemic stroke in six European countries. The EuroHOPE register study.

European journal of neurology·2014

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Mannitol, an osmotic agent and free radical scavenger, has theoretical benefits for reducing stroke-related edema and tissue damage.
  • Its potential role in managing acute ischemic stroke and cerebral parenchymal hemorrhage warrants investigation.

Purpose of the Study:

  • To evaluate the efficacy of mannitol in reducing short- and long-term case fatality and dependency after acute stroke.
  • To assess the impact of mannitol treatment on patient outcomes in stroke.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases, including Cochrane Stroke Group, MEDLINE, Chinese Stroke Trials Register, and LILACS.
  • Only truly randomized, unconfounded clinical trials comparing mannitol with placebo or open control in acute stroke patients were eligible.
  • Data extraction and analysis were performed by two independent reviewers, with methodological quality assessed.

Main Results:

  • Only one small trial with limited follow-up met the inclusion criteria.
  • The study could not demonstrate any beneficial or harmful effects of mannitol due to insufficient data.
  • Key outcomes like case fatality, dependency, and side effects were not reported or available.

Conclusions:

  • There is insufficient evidence from randomized controlled trials to support the routine use of mannitol in acute stroke.
  • Further research is required to determine the potential benefits or harms of mannitol in stroke management.
  • The current evidence does not support the widespread application of mannitol for all acute stroke patients.

Related Experiment Videos